Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 25
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04091646 | Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis | ||
| NCT07105254 | An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV) | ||
| NCT04211389 | Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis | ||
| NCT04286607 | Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis | ||
| NCT04279119 | Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis | ||
| NCT03764475 | Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis | ||
| NCT04746911 | Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) | ||
| NCT04211363 | Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis | ||
| NCT04845620 | Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED) | ||
| NCT04655313 | Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215) | ||
| NCT07077902 | A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa | ||
| NCT03392168 | Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis | ||
| NCT03638258 | The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis | ||
| NCT04773587 | Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis | ||
| NCT04811131 | Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo | ||
| NCT04804605 | Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis | ||
| NCT04378569 | Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema | ||
| NCT04773600 | Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II) | ||
| NCT04445987 | Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis | ||
| NCT04156191 | Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema | ||
| NCT05028582 | Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) | ||
| NCT04128007 | Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis | ||
| NCT06998056 | Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis | ||
| NCT03916081 | Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis | ||
| NCT04973228 | Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM) |
